These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 12391329)

  • 1. The lipid phosphatase myotubularin is essential for skeletal muscle maintenance but not for myogenesis in mice.
    Buj-Bello A; Laugel V; Messaddeq N; Zahreddine H; Laporte J; Pellissier JF; Mandel JL
    Proc Natl Acad Sci U S A; 2002 Nov; 99(23):15060-5. PubMed ID: 12391329
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Site-specific Mtm1 mutagenesis by an AAV-Cre vector reveals that myotubularin is essential in adult muscle.
    Joubert R; Vignaud A; Le M; Moal C; Messaddeq N; Buj-Bello A
    Hum Mol Genet; 2013 May; 22(9):1856-66. PubMed ID: 23390130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phosphatidylinositol 3-kinase inhibition restores Ca2+ release defects and prolongs survival in myotubularin-deficient mice.
    Kutchukian C; Lo Scrudato M; Tourneur Y; Poulard K; Vignaud A; Berthier C; Allard B; Lawlor MW; Buj-Bello A; Jacquemond V
    Proc Natl Acad Sci U S A; 2016 Dec; 113(50):14432-14437. PubMed ID: 27911767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. AAV-mediated intramuscular delivery of myotubularin corrects the myotubular myopathy phenotype in targeted murine muscle and suggests a function in plasma membrane homeostasis.
    Buj-Bello A; Fougerousse F; Schwab Y; Messaddeq N; Spehner D; Pierson CR; Durand M; Kretz C; Danos O; Douar AM; Beggs AH; Schultz P; Montus M; Denèfle P; Mandel JL
    Hum Mol Genet; 2008 Jul; 17(14):2132-43. PubMed ID: 18434328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lack of myotubularin (MTM1) leads to muscle hypotrophy through unbalanced regulation of the autophagy and ubiquitin-proteasome pathways.
    Al-Qusairi L; Prokic I; Amoasii L; Kretz C; Messaddeq N; Mandel JL; Laporte J
    FASEB J; 2013 Aug; 27(8):3384-94. PubMed ID: 23695157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myotubularin, a phosphatase deficient in myotubular myopathy, acts on phosphatidylinositol 3-kinase and phosphatidylinositol 3-phosphate pathway.
    Blondeau F; Laporte J; Bodin S; Superti-Furga G; Payrastre B; Mandel JL
    Hum Mol Genet; 2000 Sep; 9(15):2223-9. PubMed ID: 11001925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Muscle-specific alternative splicing of myotubularin-related 1 gene is impaired in DM1 muscle cells.
    Buj-Bello A; Furling D; Tronchère H; Laporte J; Lerouge T; Butler-Browne GS; Mandel JL
    Hum Mol Genet; 2002 Sep; 11(19):2297-307. PubMed ID: 12217958
    [TBL] [Abstract][Full Text] [Related]  

  • 8. X-linked myotubular and centronuclear myopathies.
    Pierson CR; Tomczak K; Agrawal P; Moghadaszadeh B; Beggs AH
    J Neuropathol Exp Neurol; 2005 Jul; 64(7):555-64. PubMed ID: 16042307
    [TBL] [Abstract][Full Text] [Related]  

  • 9. T-tubule disorganization and defective excitation-contraction coupling in muscle fibers lacking myotubularin lipid phosphatase.
    Al-Qusairi L; Weiss N; Toussaint A; Berbey C; Messaddeq N; Kretz C; Sanoudou D; Beggs AH; Allard B; Mandel JL; Laporte J; Jacquemond V; Buj-Bello A
    Proc Natl Acad Sci U S A; 2009 Nov; 106(44):18763-8. PubMed ID: 19846786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modeling the human MTM1 p.R69C mutation in murine Mtm1 results in exon 4 skipping and a less severe myotubular myopathy phenotype.
    Pierson CR; Dulin-Smith AN; Durban AN; Marshall ML; Marshall JT; Snyder AD; Naiyer N; Gladman JT; Chandler DS; Lawlor MW; Buj-Bello A; Dowling JJ; Beggs AH
    Hum Mol Genet; 2012 Feb; 21(4):811-25. PubMed ID: 22068590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. "Necklace" fibers, a new histological marker of late-onset MTM1-related centronuclear myopathy.
    Bevilacqua JA; Bitoun M; Biancalana V; Oldfors A; Stoltenburg G; Claeys KG; Lacène E; Brochier G; Manéré L; Laforêt P; Eymard B; Guicheney P; Fardeau M; Romero NB
    Acta Neuropathol; 2009 Mar; 117(3):283-91. PubMed ID: 19084976
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of novel mutations in the MTM1 gene causing severe and mild forms of X-linked myotubular myopathy.
    Buj-Bello A; Biancalana V; Moutou C; Laporte J; Mandel JL
    Hum Mutat; 1999; 14(4):320-5. PubMed ID: 10502779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of catalytically inactive lipid phosphatase myotubularin-related protein 12 impairs myotubularin stability and promotes centronuclear myopathy in zebrafish.
    Gupta VA; Hnia K; Smith LL; Gundry SR; McIntire JE; Shimazu J; Bass JR; Talbot EA; Amoasii L; Goldman NE; Laporte J; Beggs AH
    PLoS Genet; 2013 Jun; 9(6):e1003583. PubMed ID: 23818870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of myotubularin function results in T-tubule disorganization in zebrafish and human myotubular myopathy.
    Dowling JJ; Vreede AP; Low SE; Gibbs EM; Kuwada JY; Bonnemann CG; Feldman EL
    PLoS Genet; 2009 Feb; 5(2):e1000372. PubMed ID: 19197364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. rAAV-related therapy fully rescues myonuclear and myofilament function in X-linked myotubular myopathy.
    Ross JA; Tasfaout H; Levy Y; Morgan J; Cowling BS; Laporte J; Zanoteli E; Romero NB; Lowe DA; Jungbluth H; Lawlor MW; Mack DL; Ochala J
    Acta Neuropathol Commun; 2020 Oct; 8(1):167. PubMed ID: 33076971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutations in the MTM1 gene implicated in X-linked myotubular myopathy. ENMC International Consortium on Myotubular Myopathy. European Neuro-Muscular Center.
    Laporte J; Guiraud-Chaumeil C; Vincent MC; Mandel JL; Tanner SM; Liechti-Gallati S; Wallgren-Pettersson C; Dahl N; Kress W; Bolhuis PA; Fardeau M; Samson F; Bertini E
    Hum Mol Genet; 1997 Sep; 6(9):1505-11. PubMed ID: 9305655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. X-linked myotubular myopathy: report of a case with novel mutation.
    Hortobágyi T; Szabó H; Kovács KS; Bódi I; Bereg E; Katona M; Biancalana V; Túri S; Sztriha L
    J Child Neurol; 2007 Apr; 22(4):447-51. PubMed ID: 17621527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enzyme replacement therapy rescues weakness and improves muscle pathology in mice with X-linked myotubular myopathy.
    Lawlor MW; Armstrong D; Viola MG; Widrick JJ; Meng H; Grange RW; Childers MK; Hsu CP; O'Callaghan M; Pierson CR; Buj-Bello A; Beggs AH
    Hum Mol Genet; 2013 Apr; 22(8):1525-38. PubMed ID: 23307925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of activin receptor type IIB increases strength and lifespan in myotubularin-deficient mice.
    Lawlor MW; Read BP; Edelstein R; Yang N; Pierson CR; Stein MJ; Wermer-Colan A; Buj-Bello A; Lachey JL; Seehra JS; Beggs AH
    Am J Pathol; 2011 Feb; 178(2):784-93. PubMed ID: 21281811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Skeletal Muscle Pathology in X-Linked Myotubular Myopathy: Review With Cross-Species Comparisons.
    Lawlor MW; Beggs AH; Buj-Bello A; Childers MK; Dowling JJ; James ES; Meng H; Moore SA; Prasad S; Schoser B; Sewry CA
    J Neuropathol Exp Neurol; 2016 Feb; 75(2):102-10. PubMed ID: 26823526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.